(PharmaNewsWire.Com, June 05, 2019 ) According to the new market research report “Cell Lysis Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer)), Type of Cell (Microbial, Mammalian), End-User (Research Laboratories, Biopharmaceutical & Biotechnology Companies) — Global Forecast”, published by MarketsandMarkets™
The major factor driving the growth of this market are increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine
The report segments this market based on the product, type of cell, end-users, and regions. Among the various product, the consumables segment is expected to account for the largest share of the market. The consumables market includes reagents and kits, beads, and disposables. Reagents and kits are further classified into enzymes, detergent solutions, and other reagents and kits. The enzymes segment is projected to grow at the highest CAGR from 2016 to 2021. The high growth of enzymes segment can be attributed to the increasing investments for cell-based research.
Browse and in-depth TOC on “Cell Lysis Market”
84 — Tables
41 — Figures
135 — Pages
On the basis of the type of cell, the Cell Lysis Market is segmented into mammalian cells, microbial cells, and other cells. The mammalian cells segment is expected to account for the largest share of the global Cell Lysis Market. A rising aging population and increasing need for development of new cell therapies are the key factors propelling the growth of this market.
End-users, included in the Cell Lysis Market are research laboratories and institutes, biopharmaceutical and biotechnology companies, and others. The research laboratories and institutes segment is expected to account for the largest share of the global Cell Lysis Market in 2016. High incidence of diseases and research investments in life sciences is driving the growth of this market.
Based on regions, the global Cell Lysis Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as increase in the aging population, and increasing government funding in North America.
Key players in the Cell Lysis Market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), QIAGEN N.V. (Netherlands), Qsonica, LLC. (U.S.), and Thermo Fisher Scientific Inc. (U.S.).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
